Clinical trial Recruiting at 3 sites Interventional Ages 0 and up

Developing advanced MRI techniques for pediatric brain tumors

Official title: Developing Fast Pediatric Imaging

Run by Boston Children's Hospital · NCT03761121 · Data updated 2026-11-12

This study is testing new MRI techniques to see if they can help doctors get clearer images of brain tumors in children, making it easier to measure and understand the tumors.

Quick facts

Study typeInterventional
Ages0 Years and up
SexAll
Enrollment300 (estimated)
SponsorBoston Children's Hospital
Academic / other
Locations3 sites (Boston, Massachusetts and 2 other locations)
StatusRecruiting
StartedApril 15, 2019
Main results expectedSeptember 1, 2027
Study endsMarch 1, 2028
Registry record updatedDecember 12, 2025
Trial IDNCT03761121 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include infants and children diagnosed with low-grade gliomas, as well as healthy volunteers of all ages.

Probably not a fit

Patients with electrical or ferromagnetic implants, certain medical conditions, or those who are pregnant or breastfeeding may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research focuses on creating new software and techniques to enhance magnetic resonance imaging (MRI) for better evaluation of pediatric low-grade gliomas. The study aims to improve the sensitivity, specificity, and efficiency of MRI systems, allowing for more accurate measurements of brain tumor tissues. By testing investigational software, the researchers will collect and analyze MR images to refine image quality and reconstruction methods, ultimately leading to improved assessment of tumor volume.

Why it matters

Potential benefit: If successful, this could lead to more accurate diagnoses and treatment plans for children with low-grade gliomas.

How similar studies have gone: Other studies have shown promise in improving MRI techniques, but this specific approach is novel in its focus on pediatric low-grade gliomas.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Infants, children and adults who have been diagnosed with Low Grade Glioma
* Healthy volunteers - Children from age 0 to adults with no upper age limit or;
* Diagnosed with LGG and being treated at DFCI;

Exclusion Criteria:

* Electrical implants such as cardiac pacemakers or perfusion pumps;
* Ferromagnetic implants such as aneurysm clips, surgical clips, prosthesis, artificial hearts, valves with steel parts, metal fragments, shrapnel, tattoos near the eye, or steel implants;
* Ferromagnetic objects such as jewelry or metal clips;
* Women of childbearing age who are seeking to become pregnant, who are breastfeeding, or who suspect they may be pregnant;
* Pre-existing medical conditions including a likelihood of developing seizures or claustrophobic reactions;
* Any greater than normal potential for cardiac arrest

Where it's running

  • Massachusetts General Hospital
    Boston, Massachusetts, United States
    Recruiting
  • Boston Children Hospital
    Boston, Massachusetts, United States
    Recruiting
  • Dana Farber Cancer Institute
    Boston, Massachusetts, United States
    Recruiting

Study contacts

  • Principal investigator: Kawin Setsompop, PhD — Boston Children Hospital/ Massachusetts General Hospital
  • Study coordinator: Kawin Setsompop, PhD
  • Email: kawin@nmr.mgh.harvard.edu
  • Phone: 617-669-6640

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Outcomes of tone-management surgery in children with spastic/dystonic quadriplegia

    This study tests how well intrathecal baclofen pumps and dorsal/ventral rhizotomy help improve movement, comfort, and daily life for kids with severe CP and high muscle tone.

    Recruiting Boston Children's Hospital · Boston, Massachusetts · NCT07817745

  • Hematopoietic stem cell editing to treat sickle cell disease

    This study tests whether a patient’s own blood stem cells can be edited to remove the sickle cell triggering gene and then returned to the patient.

    Recruiting Phase 1 Boston Children's Hospital · Boston, Massachusetts · NCT07708350

  • Wireless ultrasound monitor for fetal health in a single pregnancy

    A single-center study will test a wireless adhesive ultrasound device on pregnant people with a singleton pregnancy to see if it can be worn comfortably and reliably for 10–30 minutes while collecting fetal and uterine data.

    Recruiting Boston Children's Hospital · Boston, Massachusetts · NCT07676474

  • Monitoring leg pressure in teens with tibia fractures

    A sensor is placed during surgery to see if measuring anterior leg pressure can help doctors spot acute compartment syndrome in teens with tibia fractures.

    Recruiting Boston Children's Hospital · Boston, Massachusetts · NCT07674043

  • Indocyanine green for diagnosing biliary atresia

    This test tries to see if a harmless fluorescent dye (indocyanine green) can show whether infants under 3 months with cholestasis have blocked bile ducts (biliary atresia).

    Recruiting Phase 1/2 Boston Children's Hospital · Boston, Massachusetts · NCT07513038

  • Fetal embolization for vein of Galen malformation in late gestation

    This study tests a one-time fetal embolization procedure for babies with vein of Galen malformations when the fetus is at least 34 weeks along.

    Recruiting Boston Children's Hospital · Boston, Massachusetts · NCT07483255

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.